Venlafaxine Hydrochloride



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Depression 41.1%
Product Used For Unknown Indication 23.7%
Anxiety 6.5%
Major Depression 4.5%
Hypertension 3.1%
Bipolar Disorder 2.7%
Pain 2.5%
Drug Use For Unknown Indication 2.2%
Insomnia 2.0%
Sleep Disorder 1.6%
Schizophrenia 1.3%
Post-traumatic Stress Disorder 1.2%
Migraine 1.1%
Prophylaxis Of Neural Tube Defect 1.1%
Convulsion 1.0%
Epilepsy 1.0%
Back Pain 0.9%
Hypercholesterolaemia 0.9%
Obsessive-compulsive Disorder 0.9%
Psychotic Disorder 0.9%
Drug Ineffective 13.1%
Completed Suicide 10.6%
Vomiting 9.4%
Serotonin Syndrome 7.8%
Toxicity To Various Agents 7.8%
Death 6.1%
Drug Abuse 4.9%
Withdrawal Syndrome 4.5%
Tachycardia 4.1%
Suicidal Ideation 3.7%
Suicide Attempt 3.7%
Drug Exposure During Pregnancy 2.9%
Premature Baby 2.9%
Respiratory Arrest 2.9%
Somnolence 2.9%
Tremor 2.9%
Weight Increased 2.9%
Drug Interaction 2.4%
Intentional Overdose 2.4%
Malaise 2.4%
Secondary
Product Used For Unknown Indication 34.0%
Depression 26.9%
Drug Use For Unknown Indication 9.3%
Anxiety 6.7%
Major Depression 3.3%
Hypertension 3.1%
Sleep Disorder 3.1%
Pain 2.6%
Bipolar I Disorder 1.9%
Panic Disorder 1.6%
Bipolar Disorder 0.9%
Gastrooesophageal Reflux Disease 0.8%
Resuscitation 0.8%
Schizophrenia 0.8%
Hypothyroidism 0.7%
Prophylaxis Of Neural Tube Defect 0.7%
Psychotic Disorder 0.7%
Arthritis 0.7%
Delirium 0.7%
Ill-defined Disorder 0.7%
Completed Suicide 12.5%
Weight Increased 10.6%
Vomiting 8.1%
Toxicity To Various Agents 6.5%
Overdose 6.2%
Drug Ineffective 5.6%
Withdrawal Syndrome 5.6%
Hyponatraemia 5.3%
Suicide Attempt 5.0%
Vision Blurred 5.0%
Ataxia 3.7%
Serotonin Syndrome 3.7%
Drug Abuse 3.1%
Suicidal Ideation 3.1%
Drug Toxicity 2.8%
Paraesthesia 2.8%
Tachycardia 2.8%
Drug Interaction 2.5%
Liver Function Test Abnormal 2.5%
Somnolence 2.5%
Concomitant
Prophylaxis 17.7%
Depression 12.7%
Drug Use For Unknown Indication 11.5%
Product Used For Unknown Indication 9.6%
Dehydration 5.6%
Cough 5.5%
Hypertension 4.5%
Fluid Replacement 4.4%
Medication Dilution 4.4%
Rheumatoid Arthritis 3.8%
Pain 3.7%
Chemotherapy 2.7%
Constipation 2.7%
Therapeutic Procedure 1.9%
Anxiety 1.7%
Hiv Infection 1.7%
Diabetes Mellitus 1.6%
Breast Cancer 1.6%
Mineral Supplementation 1.4%
Crohn's Disease 1.4%
Weight Increased 13.6%
Vomiting 12.1%
Pulmonary Embolism 8.7%
Weight Decreased 7.2%
Drug Ineffective 6.8%
Somnolence 4.2%
Urinary Tract Infection 4.2%
White Blood Cell Count Decreased 4.2%
Pain 3.8%
Suicide Attempt 3.8%
International Normalised Ratio Increased 3.4%
Nausea 3.4%
Tremor 3.4%
Vitreous Floaters 3.4%
White Blood Cell Count Increased 3.4%
Drug Interaction 3.0%
Lung Neoplasm Malignant 3.0%
Overdose 3.0%
Urticaria 3.0%
Headache 2.6%
Interacting
Depression 22.1%
Diabetes Mellitus 10.4%
Product Used For Unknown Indication 8.4%
Drug Use For Unknown Indication 7.8%
Bipolar Disorder 7.1%
Major Depression 7.1%
Back Pain 5.8%
Tachyarrhythmia 5.2%
Blood Cholesterol Increased 2.6%
Cystitis 2.6%
Drug Exposure During Pregnancy 2.6%
Dyslipidaemia 2.6%
High Density Lipoprotein Decreased 2.6%
Anxiety 1.9%
Dysthymic Disorder 1.9%
Epilepsy 1.9%
Hepatitis C 1.9%
Smoking Cessation Therapy 1.9%
Type 1 Diabetes Mellitus 1.9%
Asthenia 1.3%
Drug Interaction 17.5%
Urinary Retention 12.5%
Myocardial Infarction 10.0%
Serotonin Syndrome 10.0%
Toxicity To Various Agents 10.0%
Tremor 10.0%
Hyperhidrosis 5.0%
Withdrawal Syndrome 5.0%
Accidental Overdose 2.5%
Hypoplastic Right Heart Syndrome 2.5%
Medication Error 2.5%
Neuroleptic Malignant Syndrome 2.5%
Neutropenia 2.5%
Therapeutic Response Decreased 2.5%
Urinary Tract Infection 2.5%
Weight Decreased 2.5%